Abir (2017) |
Tel Aviv, Israel |
9 |
13–31 |
N/A |
Postpubertal woman prior to anticancer therapy |
Laparoscopy |
Amorim (2012) |
Brussels, Belgium |
7 |
30–41 |
N/A |
Benign gynecologic conditions |
Laparoscopy |
Borras (2022) |
Barcelona, Spain |
18 |
20–40 |
26.6 ± 5.5 |
Transgender |
Gender affirming surgery including hysterectomy and bilateral adnexectomy |
Chang (2011) |
Seoul, South Korea |
11 |
20–41 |
31.9 |
Benign cysts or cesarean section |
Laparoscopy |
Fabbri (2016) |
Bologna, Italy |
6 |
14–34 |
24.5 ± 9.3 |
Hodgkin lymphoma, breast cancer, brain tumor, and medulloblastoma |
Laparoscopy |
Galbinski (2022) |
Brazil |
12 |
N/A |
34.6 ± 3.2 |
Not specified |
Laparoscopy |
Gandolfi (2006) |
Milan, Italy |
3 |
26–33 |
N/A |
Monolateral endometrioma |
Laparoscopy |
Herraiz (2014) |
Valencia, Spain |
8 |
18–37 |
27 |
Breast cancer and Hodgkin lymphoma |
Not specified |
Keros (2009) |
Stockholm, Sweden |
20 |
28–43 |
33.3 ± 4.0 |
Planned cesarean sections |
Not specified |
Lee (2019) |
Seoul, South Korea |
19 |
15–32 |
N/A |
Not specified |
Not specified |
Li (2007) |
Guangzhou, China |
15 |
22–37 |
33.1 ± 2.9 |
Benign ovarian cysts |
Laparoscopy or open |
Oktem (2011) |
Turkey |
15 |
N/A |
32.2 ± 2.8 |
Benign ovarian cyst |
Laparoscopy |
Ramos (2021) |
Brazil |
9 |
29–39 |
34.6 ± 3 |
Unspecified gynecological conditions |
Laparoscopy |
Sanfillipo (2015) |
Clermont-Ferrand, France |
5 |
N/A |
28.0 ± 1.1 |
Benign ovarian cyst |
Laparoscopy |
Sugishita (2021) |
New Haven, Connecticut, USA |
5 |
N/A |
31 ± 6.62 |
Cadavers |
Not specified |
Wang (2008) |
Sichuan, China |
5 |
21–37 |
N/A |
Endometrial cancer, cervical cancer, and breast cancer |
Oophorectomy or ovarian biopsy |
Xiao (2010) |
Sichuan, China |
10 |
21–36 |
30 (median) |
Not specified |
Oophorectomy or ovarian cystectomy |
Xiao (2013) |
Sichuan, China |
6 |
21–36 |
N/A |
Not specified |
Oophorectomy or ovarian cystectomy |
Zhao (2019) |
Zhengzhou City, China |
18 |
N/A |
37.9 ± 6.4 |
Not specified |
Laparoscopy or open |